Related Experiment Video
Updated: Jul 5, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
TCF7L2 genetic defect and type 2 diabetes.
Current Diabetes Reports
|May 1, 2008
Summary
Genetic studies reveal transcription factor 7-like 2 (TCF7L2) as a key gene influencing type 2 diabetes (T2D) risk across ethnic groups. This finding offers insights into T2D genetic predisposition and beta cell function.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- Type 2 Diabetes (T2D) genetic architecture has been challenging to unravel.
- Recent advances have identified key genes involved in pancreatic beta cell function and insulin secretion.
Purpose of the Study:
- To highlight the significant role of the TCF7L2 gene in T2D susceptibility.
- To discuss the implications of TCF7L2 polymorphisms on T2D risk and beta cell function.
Main Methods:
- Genome-wide association scans (GWAS) in European populations.
- Analysis of TCF7L2 gene expression and its association with T2D risk alleles.
- Examination of TCF7L2's role in Wnt signaling pathway and insulin secretion.
Main Results:
- TCF7L2 is the most significant T2D predisposing locus identified in Europeans to date.
- TCF7L2 polymorphisms are consistently associated with T2D susceptibility across major ethnic groups.
- The TCF7L2 rs7903146 risk allele increases TCF7L2 gene expression in beta cells, potentially affecting insulin secretion and beta cell development.
Conclusions:
- TCF7L2 plays a crucial, consistent role in T2D susceptibility globally.
- Understanding TCF7L2's function provides new avenues for T2D genetic predisposition testing.
- The identified TCF7L2 associations represent a significant, yet incomplete, understanding of T2D's genetic basis.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:27Glucose Transporters
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: